SOTERA HEALTH COMPANY Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
SOTERA HEALTH COMPANY (SHC) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$17.52 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-06
- SOTERA HEALTH COMPANY other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$17.52M, a 121.58% decline year-over-year.
- SOTERA HEALTH COMPANY other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$16.10M, a 185.66% decline year-over-year.
- SOTERA HEALTH COMPANY other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $15.67M.
- SOTERA HEALTH COMPANY other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was -$17.22M, a 182.87% decline year-over-year.
- SOTERA HEALTH COMPANY other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $98.41M.
- SOTERA HEALTH COMPANY other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$115.57M, a 927.21% decline from fiscal 2023.
- SOTERA HEALTH COMPANY other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $13.97M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$17.52M 10-Q · filed 2026-08-06 | -$33.62M 10-Q · filed 2026-08-06 | -$17.95M derived: sum of 3 quarters · filed 2026-08-06 | -$35.17M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$16.10M 10-Q · filed 2026-05-05 | -$433.00K derived: sum of 2 quarters · filed 2026-05-05 | -$17.65M derived: sum of 3 quarters · filed 2026-05-05 | $63.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $15.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.55M derived: sum of 2 quarters · filed 2026-02-24 | $79.61M derived: sum of 3 quarters · filed 2026-08-06 | $98.41M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$17.22M 10-Q · filed 2025-11-04 | $63.95M derived: sum of 2 quarters · filed 2026-08-06 | $82.74M 10-Q · filed 2025-11-04 | -$888.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $81.17M 10-Q · filed 2026-08-06 | $99.96M 10-Q · filed 2026-08-06 | $16.33M derived: sum of 3 quarters · filed 2026-08-06 | $37.11M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $18.80M 10-Q · filed 2026-05-05 | -$64.83M derived: sum of 2 quarters · filed 2026-05-05 | -$44.06M derived: sum of 3 quarters · filed 2026-05-05 | -$69.60M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$83.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$62.85M derived: sum of 2 quarters · filed 2026-02-24 | -$88.39M derived: sum of 3 quarters · filed 2026-02-24 | -$115.57M 10-K · filed 2026-02-24 |
| 2024-09-30 | $20.78M 10-Q · filed 2025-11-04 | -$4.76M derived: sum of 2 quarters · filed 2025-11-04 | -$31.94M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | -$25.54M 10-Q · filed 2025-08-08 | -$52.72M 10-Q · filed 2025-08-08 | ||
| 2023-12-31 | $13.97M 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |